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erThe Affordable Care Act has led to signiﬁcant gains in insurance coverage and reduced the cost of
preventive care for millions of Americans. There is considerable interest in understanding how these
changes will impact the use of preventive care services and health outcomes. Obtaining unbiased estimates
of the impact of insurance on these outcomes is challenging because of inherent differences between
insured and uninsured individuals. This article reviews common experimental and quasi-experimental
approaches researchers have used in the past to address this problem, including RCTs, differences-in-
differences analyses, and regression discontinuity. In each case, the key assumptions underlying
the models are discussed alongside some of the main research ﬁndings related to prevention and health.
The review concludes with a discussion of how experimental and quasi-experimental methods can be used
to study the impact of the Affordable Care Act on preventive care and health outcomes.
(Am J Prev Med 2016;50(5S1):S27–S33)& 2016 American Journal of Preventive Medicine. All rights reserved. This is
an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).IntroductionThe passage of the Affordable Care Act (ACA)resulted in new insurance coverage for at least 16million Americans.1-3 In addition to expanding
insurance to previously uninsured individuals, the law
also includes several provisions designed to enhance the
coverage of preventive services. Most notably, individuals
newly covered through the health insurance market-
places must be provided with an essential health beneﬁts
package that includes preventive care. The law also
mandates that all private insurance plans and Medicare
cover evidence-based preventive services without any
cost sharing.4 The ACA deﬁnes covered preventive
services for three populations: adults, women (including
pregnant women), and children. There is considerable
interest in understanding how this enhanced coverage of
preventive services will impact the use of preventive care
and health outcomes. This article reviews some of the key
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outcomes and discusses how future research might build
on this work to examine the effects of the ACA.
Prior evidence on the impact of coverage is mixed, in
large part owing to the difﬁculty of obtaining unbiased
estimates because of differences between insured and
uninsured individuals.5 Simply put, people without
insurance differ from those with insurance in terms of
sociodemographics, health behaviors, propensity to use
health care, and baseline health status. Studies in the
literature have dealt with this problem to varying degrees.
Cross-sectional observational and longitudinal studies, of
which there are hundreds, typically compare outcomes
for insured and uninsured individuals and (in some
cases) control for covariates such as income, age, gender,
or health behaviors. Although they typically document a
positive association among coverage, receipt of preven-
tive services, and health, these studies do not adequately
address selection bias; even if they adjust for measured
differences, many of the potential confounders are either
not fully measured or simply not captured at all.6 For this
reason, this review focuses on experimental and quasi-
experimental methods that use variation in health
insurance coverage that is plausibly unrelated to pre-
vention and health.
Experimental Methods
The ideal study of the causal effect of coverage on
preventive care and health outcomes would randomlyhis is an open access
/licenses/by-nc-nd/4.0/).
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coverage and other individuals to remain uninsured or to
receive an alternative type of coverage. This method
allows researchers to compare the use of preventive care
and health outcomes across groups—one or more treat-
ment groups and a control group—without any selection
bias or confounding.
There have been only a handful of large-scale, exper-
imental studies of the impact of health insurance in the
U.S. The ﬁrst was the RAND Health Insurance Experi-
ment (HIE), conducted between 1971 and 1982 to
evaluate how cost sharing, how much patients have to
pay for each service, and plan type affect service use
(including preventive care) and health outcomes. The
experiment found signiﬁcant decreases in healthcare
utilization when individuals faced higher cost-sharing
requirements, though the health impacts of these changes
were generally small or non-existent for all but the most
vulnerable patients in the study.7 A more recent non-
randomized study examining high-deductible health
plans offers support for some of the HIE’s key ﬁndings,
observing that patients reduce the use of potentially
valuable care (e.g., preventive care) and potentially
wasteful care (e.g., imaging) when faced with higher cost
sharing.8
These results suggest that the reductions in cost
sharing for prevention in the ACA may increase the
use of preventive services for those with insurance prior
to the ACA. However, because all participants in the HIE
study had some form of health insurance, the ﬁndings are
not relevant to the impact on those newly insured with
the ACA.
Fortunately, the Oregon HIE (OHIE) examines the
impact of coverage on the previously uninsured. The
OHIE was an evaluation of the causal impact of Medicaid
on utilization, ﬁnancial strain, and health outcomes. The
study was made possible by Oregon’s Medicaid expan-
sion in the 2000s, in which demand outpaced state
funding, leading to the creation of a waitlist. In 2008,
the state conducted a lottery to determine which indi-
viduals on the waitlist could apply to participate in the
Medicaid expansion. Even though not all people selected
by the lottery enrolled in Medicaid, selection increased
the probability of Medicaid coverage by 24.1 percentage
points, allowing the researchers to estimate the effect of
Medicaid.9
In the study’s ﬁrst year, Medicaid increased the like-
lihood of being admitted to the hospital, using outpatient
care, and using prescription drugs. The researchers also
examined four measures of preventive care: cholesterol
testing, blood tests for diabetes, mammograms, and Pap
tests. Medicaid led to statistically signiﬁcant increases in
each of these measures, with particularly large increasesin the probability of having received a mammogram
(60% relative increase) or a Pap test within the last year
(45% relative increase). Medicaid also improved self-
reported physical and mental health, increasing the
probability that people reported being in good or
excellent health by 25% and reducing the probability of
a positive screen for depression by 10%.10
In the study’s second year, the researchers examined a
wider set of clinical outcomes and preventive services. Of
21 clinical measures and health outcomes, Medicaid
coverage had a statistically signiﬁcant impact on ﬁve
measures related to depression and diabetes, including a
reduction in the rate of depression and increased rates of
new diagnosis for diabetes and current use of medica-
tions for diabetes.11 They found no statistically signiﬁ-
cant impact of Medicaid on other clinical outcomes,
including measured blood pressure, cholesterol, and
blood sugar control, though whether this reﬂected a true
null effect or in some cases an underpowered study
design remains a source of debate.12 In addition to
clinical outcomes, the researchers examined the use of
seven preventive care services. They found that Medicaid
coverage led to signiﬁcant increases in the use of
cholesterol screening, Pap tests, prostate-speciﬁc antigen
screening, and mammography, but did not produce
signiﬁcant changes in receipt of colorectal cancer screen-
ing or inﬂuenza vaccination.11
The OHIE provides strong evidence that Medicaid
coverage increases the use of some preventive services
while improving self-reported health. Similar ﬁndings
were noted in a smaller RCT featuring accelerated health
insurance beneﬁts for disabled individuals who did not
yet qualify for Medicare coverage: In that study, signiﬁ-
cant increases were noted in self-reported health, overall
physical and mental health (using the Short-Form 36
questionnaire), and healthcare utilization.13 It is unclear
whether these two studies can be generalized to newly
covered individuals in the ACA, as roughly half are
expected to gain private health insurance rather than
Medicaid or Medicare.
Although RCTs provide valuable evidence on the
causal impact of health insurance, they have limitations.
First, time and cost constraints can limit sample size,
making it difﬁcult to detect effects on rare or longer-term
outcomes (such as mortality), which has been one
prominent critique of the OHIE. Second, RCT study
procedures, such as intensive follow-up with patients,
may limit generalizability because they differ from
normal patterns of care. In addition, RCTs typically
impact a small population and may not generalize to
larger policy changes that may reshape healthcare
markets or alter the behavior of doctors, hospitals, and
insurers. Finally, in the design of RCTs, researchers face awww.ajpmonline.org
Figure 1. Stylized depiction of a differences-in-differences
analysis.
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(e.g., what impact does expanding health insurance have
on the use of preventive care?) and distinguishing the
causal mechanisms (e.g., why does health insurance
impact the use of preventive care?).14 Some of these
disadvantages are not present in quasi-experimental
methods that, under the right conditions, allow research-
ers to estimate the causal impact of insurance using larger
samples—sometimes even population-level data—under
more typical real-world circumstances.15,16
Quasi-experimental Methods
Quasi-experimental analyses use natural experiments to
identify sources of variation in coverage that are plausibly
unrelated to the outcomes being studied, for example,
preventive care and health outcomes. Natural experi-
ments in health insurance can arise from changes in
coverage policy, the use of strict cut offs to determine
eligibility (e.g., age or income), or differences in coverage
policies across groups of individuals. Though numerous
methods have been developed to study natural experi-
ments, this review focuses on two of the most common:
differences-in-differences analysis (DD) and regression
discontinuity (RD).
Differences-in-Differences Analysis
Perhaps the most common quasi-experimental method
used to study the impact of insurance expansions is DD.
In the basic setup, researchers observe outcomes for a
treatment group impacted by the expansion and a
control group not subject to the expansion. The DD
estimator is the average difference in the outcome for the
treatment group before and after treatment, minus the
average difference in the outcome for the control group
before and after treatment—hence, the term differences-
in-differences (sometimes also called “difference-in-dif-
ferences” in the literature). For those more familiar with
interrupted time series, DD is somewhat analogous to
interrupted time series with a control group, except that
in a DD approach, the outcome is modeled based on the
mean pre-policy versus mean post-policy level, whereas
interrupted time series models specify a pre-policy time
trend versus a post-policy time trend. Although both
approaches typically produce similar results—and some
papers present both sets of results—there are relative
advantages and disadvantages to each, depending on the
underlying data, sample size, and expected evolution of
policy effects over time.
There are many variations on DD, but all share the
common assumption that trends in the outcomes prior to
the expansion must be parallel across the treatment and
control groups—in other words, in the absence of theMay 2016policy change, the two groups would have continued to
move in tandem. Figure 1 presents a stylized example of
outcomes that can be analyzed using a DD model.
Notably, the DD model does not require that the treat-
ment and control groups have the same average outcome
before the policy/treatment, as long as the pre-policy
trends in those outcomes are similar.17 In some cases,
researchers relax the common trends assumption and
include controls for group-speciﬁc time trends. In these
models, the assumption is that outcomes would follow
the linear, group-speciﬁc trend in the absence of inter-
vention (“parallel growth” rather than “parallel trends”).
However, because data are noisy and there may be lags
between an intervention and the change in an outcome, it
can be difﬁcult to distinguish treatment effects from
differential trends in these models.18
Such DD methods have been used to study the
creation of Medicare in 1965, state Medicaid expansions
in the 1980s through the 2000s, Massachusetts’ landmark
2006 statewide health reform that served as the model for
the ACA, and the 2010 dependent coverage provision of
the ACA.
To study the impact of Medicare, which was a federal
law with uniform eligibility criteria across states, Finkel-
stein and McKnight19 constructed control groups by
exploiting geographic differences in when the law went
into effect or by identifying areas where the policy had
smaller or larger impacts because of different preexisting
coverage rates. In addition, the researchers analyzed
trends in coverage and health outcomes for individuals
aged younger and older than 65 years around the
introduction of Medicare. A concern with deﬁning the
treatment and control groups using age was that trends
in their outcomes diverged prior to 1965, but reassur-
ingly, each of these approaches led to similar ﬁndings,
with the authors concluding that the creation of Medi-
care produced large effects on healthcare utilization and
spending, but no discernible impact on mortality.
Another strain of DD studies examined how the impact
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uninsured adults, showing that previously uninsured
adults experienced greater gains in health outcomes with
the onset of Medicare coverage and also consumed more
services than those previously insured.20-22
In the case of prior Medicaid expansions, control
groups were more readily available, as they typically
occurred as a result of some states electing to expand and
others not doing so, or new Congressional requirements
prompting states that had previously been less generous
in their eligibility to catch up to the new federal
minimum standards. A series of such DD studies have
shown that Medicaid expansions increase the use of
primary care, prenatal care, and hospital care,23 and
mixed evidence on prenatal care and infant mortality.24-26
State Medicaid expansions among adults were found to
improve access to care and self-reported health and to
reduce mortality, particularly in low-income counties and
minority groups.15
The DD framework has also been used extensively to
study the 2006 Massachusetts health reform. Researchers
have typically compared Massachusetts with nearby
states or New England as a whole, and have documented
a wide range of improvements in access to care, self-
reported health,27,28 Pap tests,29 primary care, and rates
of inﬂuenza vaccination,30 but mixed evidence on
admissions for ambulatory sensitive conditions31,32 and
mammography rates.29,33 Another analysis of this policy
created a control group of demographically and eco-
nomically similar counties from outside the state to
compare with counties in Massachusetts, before and
after the reform. The study found a signiﬁcant decline
in statewide mortality for non-elderly adults, with
changes concentrated among causes of death more likely
to be amenable to health care, such as heart disease,
cancer, and infections.16
Most recently, the dependent coverage provision of the
ACA has created an opportunity to evaluate the expan-
sion of private health insurance. The policy, which
allowed children to remain on their parents’ plans until
age 26 years, was implemented beginning in 2010. Using
a DD framework, researchers have compared outcomes
for young adults impacted by the policy (aged 1926
years) with control groups that were unaffected because
they were too young (aged 1618 years, and already
eligible to remain on their parents’ plans) or too old (aged
2730 years). Although many states already had depend-
ent coverage mandates in place, these mandates were
much weaker than the 2010 federal policy.34 The
mandate led to large increases in health insurance
coverage for young adults, as well as improvements in
access to care, affordability, and self-reported health.35-37
The estimated impact on utilization and prevention hasbeen mixed: One study found increased utilization of
hospital care,38 others have shown a decline in emer-
gency department use, especially for outpatient-treatable
conditions,39 and a recent study showed improved rates
of vaccination against human papillomavirus among
young women.40
Overall, recent DD analyses have helped clarify the
impacts of coverage on prevention and health using large
sample sizes and at much lower cost than operating a
social experiment. Though DD analyses require stronger
assumptions than RCTs, a useful feature of this study
design is that the assumption of parallel trends can be
veriﬁed graphically and statistically. DD methods can
also be used to evaluate both binary and continuous
outcomes. For binary outcomes, nonlinear models may
be used in the DD framework, but because of their
straightforward interpretation, many researchers favor
linear probability models when working with binary
outcomes.41
It is important to note, however, that even if parallel
trends exist prior to the policy change being studied, it
does not rule out the possibility that time-varying
confounders in the treatment and control states could
have inﬂuenced the results. For example, individual
behavior may change in anticipation of a new policy.
Alternatively, the timing of the policy change may be
endogenous—meaning that the policy change itself was
driven by confounding factors that may impact the study
outcomes. For example, states may expand Medicaid
when the economy is strong, which may independently
impact health outcomes. Researchers must rule out these
and other alternative explanations for a divergence in
trend across treatment and control after the policy
change.
Finally, DD papers often use data from many years (or
periods) before and after the intervention and examine
serially correlated outcomes (e.g., insurance status).
Researchers must carefully correct for this serial corre-
lation when calculating SEs. Several approaches have
been suggested, including collapsing the data and ignor-
ing the time series variation or clustering SEs by group or
time (or ideally both).42Regression Discontinuity
Another quasi-experimental approach involves identify-
ing discontinuities created by policies, which offer a
chance to identify the policies’ impact. Access to public
insurance programs is determined by a set of eligibility
criteria; as described in the last section, some of these
criteria are discrete—living in an expansion state versus a
non-expansion state, for instance, which lends itself
naturally to a DD approach. In other cases, the criteriawww.ajpmonline.org
Figure 2. Stylized depiction of a regression discontinuity
analysis.
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exploit cut offs in the continuous measures (called the
“running” or “forcing” variable) that allow researchers to
identify treatment and control individuals that are
similar except for being on one side or the other of the
cut off point. These techniques have been used to
evaluate the impact of Medicaid by using sharp cut offs
in income criteria, and to study the impact of Medicare
by examining outcomes for individuals just below and
above the age 65 years eligibility cut off. In each case, the
researchers must establish that treatment assignment
(being on either side of the cut off)—for those close to
the cutoff—is exogenous, meaning that it does not vary in
a systematic way with the outcomes being studied. Put
differently, individuals must not be able to manipulate
their income or age to determine their treatment status,
which would bias the study design.43 RD models adjust
for the potential confounding effect of the running
variable over the sample range (either with linear or
polynomial controls or using local linear regression), and
then identify the change in outcomes caused precisely at
the point of the discontinuity as the policy’s causal effect.
Recent advances provide data-driven criteria for selecting
the optimal bandwidth around the cut off when estimat-
ing an RD model with local linear regression.44 Figure 2
demonstrates a stylized description of an RD analysis.
The RD approach has been used to examine the effects
of Medicare coverage by comparing individuals on either
side of the eligibility threshold at age 65 years. RD
estimates have demonstrated evidence of an increase in
the use of preventive services related to breast cancer,45
voluntary procedures like knee and hip replacements,46
and reductions in mortality.47
Others have used Medicaid eligibility criteria to con-
duct RD analyses. In Wisconsin, applications for a
Medicaid beneﬁt plan exceeded projections, leading the
state to announce that applications received after aMay 2016speciﬁc date would be placed on a waitlist. Researchers
constructed a treatment group of individuals whose
applications were received just before the cut off and
compared their outcomes with a control group of
individuals whose applications were received just after
the cut off. The study showed that a rural Medicaid
expansion led to increases in outpatient visits and
inpatient stays, but no effect on emergency department
use.48 These results can be interpreted as causal estimates
if assignment to treatment was indeed quasi-random,
meaning that individuals who just missed the deadline
did not differ signiﬁcantly from individuals whose
applications came in just before the deadline. RD
methods have also been used to assess discontinuities
in income-related premiums for coverage49 and Medic-
aid eligibility guidelines across states.50
The RD design provides strong internal validity,
similar to a DD analysis, if the key assumptions for both
models are met. For RD models, the key assumptions are
testable and treatment effects ideally are visible in a
scatterplot of the outcome against the running variable.
The external validity of RDs, however, is often more
limited. RDs provide an estimate of a local treatment
effect at the discontinuity. For example, analyses that use
the Medicare eligibility age as the discontinuity produce
estimates of the impact of Medicare coverage at age
65 years. These ﬁndings may not be informative about
the impact of Medicare coverage for older individuals.
Conclusions and Future Directions
Numerous high-quality studies have used a wide range of
methods to study the impact of health insurance on
prevention and health. In contrast to simple cross-
sectional or cohort studies, both experimental and
quasi-experimental approaches offer methodologic sol-
utions to a key source of confounding: unmeasured or
unobserved differences between insured and uninsured
individuals.
Because the ACA is a policy change (and a very large
one at that), rather than a social experiment, researchers
will primarily have to rely on quasi-experimental
approaches to evaluate its impact. As the ACA was
implemented nationally, identifying plausible control
groups will be challenging for some components of the
law. However, some aspects of the ACA—like the depend-
ent coverage provision—lend themselves to quasi-
experimental analyses. This work will continue as data
become available for those newly insured through Medic-
aid expansions and the health insurance marketplaces.
Even though the ACA was federal legislation, the
Supreme Court ruling in 2012 rendered the Medicaid
expansion a state option. The result has been signiﬁcant
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to expand coverage, and how to do so, with some states
pursuing alternative expansions such as Arkansas’s so-
called private option.51,52 These changes all naturally lend
themselves to studying the impact of Medicaid and
alternative coverage designs in a DD framework, which
some preliminary research has already done.53
Meanwhile, the new criteria for both Medicaid and
marketplace coverage include income cut offs that lead to
various discontinuities in eligibility, premiums, and cost-
sharing subsidies. Studying these policies via RD meth-
ods can yield important insights into the relative impacts
of Medicaid, private coverage, and insurance plan design.
Finally, RCTs as part of various demonstration projects
under the ACA—designed to improve the cost effective-
ness and quality of care—will also be important items in
health policy researchers’ toolkits, and policymakers would
be wise to consider the value of randomization when
implementing innovative new approaches to coverage and
care delivery, in order to better inform future policy efforts.
Taken together, these alternative approaches will be
critical to conducting high-quality research not only to
assess the impact of the ACA as a piece of legislation, but
also for gathering new evidence about the broader
impacts of insurance on prevention and health.
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